The stock’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.69. Organovo has a 52-week low of $0.40 and a 52-week high of $2.05. Get Organovo alerts: ...

Research analysts at StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVO – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the ...

Roth Capital Partners is managing the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Organovo Holdings (NASDAQ:ONVO) just reported results for the fourth quarter of 2024. Organovo Holdings reported earnings per ...

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...

Gainers: Universe Pharmaceuticals (UPC) +17%. Solid Biosciences SLDB +14%. Inogen (INGN) +15%. Organovo (ONVO) +14%. Fortress Biotech (FBIO) +12%. Losers: ZyVersa ...

S&P 500 funds are inexpensive and share many similarities, but you'll find small differences in cost and how closely they track their benchmark.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...